Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 13317
Country/Region: Uganda
Year: 2016
Main Partner: Joint Clinical Research Center
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $1,857,988 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $508,150
Care: TB/HIV (HVTB) $122,743
Care: Pediatric Care and Support (PDCS) $161,355
Laboratory Infrastructure (HLAB) $0
Testing: HIV Testing and Counseling (HVCT) $8,140
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $613
Treatment: Adult Treatment (HTXS) $998,877
Treatment: Pediatric Treatment (PDTX) $58,110
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: <1 2017 36
HTS_TST Age/sex: 1-9 2017 119
HTS_TST Age/sex: 10-14 Female 2017 103
HTS_TST Age/sex: 10-14 Male 2017 102
HTS_TST Age/sex: 15-19 Female 2017 273
HTS_TST Age/sex: 15-19 Male 2017 292
HTS_TST Age/sex: 20-24 Female 2017 410
HTS_TST Age/sex: 20-24 Male 2017 438
HTS_TST Age/sex: 25-49 Female 2017 629
HTS_TST Age/sex: 25-49 Male 2017 672
HTS_TST Age/sex: 50+ Female 2017 55
HTS_TST Age/sex: 50+ Male 2017 58
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 181
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 179
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 1,367
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 1,460
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 3,187
HTS_TST Service Delivery Point (Facility): Index testing 2017 675
HTS_TST Service Delivery Point (Facility): Inpatient 2017 505
HTS_TST Service Delivery Point (Facility): Other PITC 2017 391
HTS_TST Service Delivery Point (Facility): Outpatient 2017 1,079
HTS_TST Service Delivery Point (Facility): Pediatric 2017 349
HTS_TST Service Delivery Point (Facility): PMTCT 2017 160
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 28
HTS_TST Sum of Age/Sex disaggregates 2017 3,032
HTS_TST Sum of Aggregated Age/Sex <15 2017 360
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 2,827
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 3,187
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 6
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 5
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 16
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 12
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 24
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 18
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 37
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 28
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 4
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 3
HTS_TST_POS Test Result by Age: Positive: <1 2017 2
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 6
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 10
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 9
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 81
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 61
PMTCT_ART Already on ART at beginning of current pregnancy 2017 8
PMTCT_ART New on ART 2017 5
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 160
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 9
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 3
PMTCT_EID Sum of Infant Age disaggregates 2017 12
PMTCT_STAT By: Known positives at entry 2017 7
PMTCT_STAT By: Number of new positives identified 2017 7
PMTCT_STAT Number of new ANC and L&D clients 2017 165
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 160
PMTCT_STAT Sum of Positives Status disaggregates 2017 14
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 4
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 4
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 1,789
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 179
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 537
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 1,073
TB_SCREENDX Screen Result: Screened Positive for TB 2017 447
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 13,726
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 7,068
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 834
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 739
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 22,367
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 2
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 7
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 9
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 9
TX_CURR Age/Sex: <1 2017 63
TX_CURR Age/Sex: <1-9 2017 376
TX_CURR Age/Sex: 10-14 Female 2017 609
TX_CURR Age/Sex: 10-14 Male 2017 525
TX_CURR Age/Sex: 15-19 Female 2017 686
TX_CURR Age/Sex: 15-19 Male 2017 212
TX_CURR Age/Sex: 20-24 Female 2017 3,157
TX_CURR Age/Sex: 20-24 Male 2017 1,414
TX_CURR Age/Sex: 25-49 Female 2017 9,197
TX_CURR Age/Sex: 25-49 Male 2017 5,089
TX_CURR Age/Sex: 50+ Female 2017 686
TX_CURR Age/Sex: 50+ Male 2017 353
TX_CURR Aggregated Age/Sex: <15 Female 2017 834
TX_CURR Aggregated Age/Sex: <15 Male 2017 739
TX_CURR Aggregated Age/Sex: 15+ Female 2017 13,726
TX_CURR Aggregated Age/Sex: 15+ Male 2017 7,068
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 22,367
TX_CURR Sum of age/sex disaggregates 2017 898
TX_CURR Sum of Aggregated Age/Sex <15 2017 1,573
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 20,794
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 22,367
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 47
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 41
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 998
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 514
TX_NEW By Age/Sex: <1 2017 4
TX_NEW By Age/Sex: 1-9 2017 21
TX_NEW By Age/Sex: 10-14 Female 2017 34
TX_NEW By Age/Sex: 10-14 Male 2017 29
TX_NEW By Age/Sex: 15-19 Female 2017 50
TX_NEW By Age/Sex: 15-19 Male 2017 15
TX_NEW By Age/Sex: 20-24 Female 2017 230
TX_NEW By Age/Sex: 20-24 Male 2017 103
TX_NEW By Age/Sex: 25-49 Female 2017 669
TX_NEW By Age/Sex: 25-49 Male 2017 370
TX_NEW By Age/Sex: 50+ Female 2017 49
TX_NEW By Age/Sex: 50+ Male 2017 26
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,600
TX_NEW Sum of Age/Sex disaggregates 2017 1,575
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,600
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 17,894
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 16,105
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 600
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 532
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 9,879
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 5,094
TX_PVLS Numerator: Indication: Routine 2017 16,105
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 667
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 591
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 10,978
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 5,658
TX_PVLS_den Denominator: Indication: Routine 2017 17,894
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 9
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 11
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 13
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 13
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 17
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 60
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 176
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 399
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 13
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 135
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 16
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 19
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 262
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 554
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 851
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 956
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 9
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 13
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 15
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 15
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 19
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 68
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 125
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 197
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 449
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 14
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 30
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 18
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 21
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 294
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 623
Cross Cutting Budget Categories and Known Amounts Total: $150,000
Human Resources for Health $100,000
Key Populations: Sex Workers $50,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Conducting epidemiologic, social science, and operational research among SWs, their partners, and clients
Monitoring and evaluation of SW programs
Procurement of condoms, lubricants, and other commodities essential to core HIV services for SWs